Prognostic factors for response and overall survival in 282 patients with higher-risk myelodysplastic syndromes treated with azacitidine. (Q50558385)
Jump to navigation
Jump to search
scientific article published on 12 October 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Prognostic factors for response and overall survival in 282 patients with higher-risk myelodysplastic syndromes treated with azacitidine. |
scientific article published on 12 October 2010 |
Statements
Prognostic factors for response and overall survival in 282 patients with higher-risk myelodysplastic syndromes treated with azacitidine (English)
Pierre Fenaux
Lionel Adès
Jacques Delaunay
Caroline Dartigeas
Pascal Turlure
Sylvain Thépot
Odile Beyne-Rauzy
Norbert Vey
Christian Recher
Laurence Legros
Sorin Visanica
Aspasia Stamatoullas
Francoise Isnard
Anne Marfaing-Koka
Youcef Chelghoum
Anne-Laure Taksin
Isabelle Plantier
Francois Dreyfus
Célia Salanoubat
Shanti Ame
Simone Boehrer
Claude Gardin
C L Beach
Groupe Francophone des Myelodysplasies(GFM)
12 October 2010